Study of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban
Clinical trial NCT02975453 · COMPLETED
Trial details
- NCT number
- NCT02975453
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-05
- Primary completion
- 2020-03-18
- Enrollment
- 1481
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.